Pharmacological enhancement of fibrinolytic activity and 125I-fibrinogen survival
AUTOR(ES)
Hickman, J. A.
RESUMO
Studies with 125I-fibrinogen after the administration of phenformin plus ethyloestrenol in five subjects showed no evidence of enhanced catabolism of fibrinogen despite a fall in plasma fibrinogen concentration and shortened clot lysis time. It seems probable that the fall in plasma fibrinogen concentration after the administration of these drugs is related to diminished hepatic synthesis of fibrinogen and is independent of the induction of plasminogen activator release.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=476900Documentos Relacionados
- In vitro assay of thrombolysis with 125I-fibrinogen.
- Pharmacological enhancement of fibrinolytic activity of blood
- The study of 131I-fibrinogen in humans
- Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in acute myocardial infarction.
- Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen.
